Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FV5VJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,109
Award facts
- Contract value 100% obligated
- $22,109.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,109.43 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen injections (2 mL) on October 24, 2025, with completion targeted for October 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company maintains an extensive portfolio of federal contract awards covering diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. This delivery order for Cosentyx, a specialty biologic medication used to treat inflammatory conditions, reflects AmerisourceBergen's ongoing role in supplying specialized pharmaceutical products to support Department of Defense and military healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FV5VJ?
SPE2DB26FV5VJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FV5VJ worth?
The government has obligated $22,109 on SPE2DB26FV5VJ.
Is contract SPE2DB26FV5VJ an order under another contract?
Yes. SPE2DB26FV5VJ is a delivery order under SPE2DB22D2006, an indefinite delivery contract.
Was contract SPE2DB26FV5VJ competed?
The extent of competition for SPE2DB26FV5VJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award